Torrent Pharmaceuticals sold 50,000 equity shares of UNM Foundation (Section 8 Company) to its holding company Torrent Investments Limited on March 30, 2026.
Total consideration received was ₹5,00,000 (face value ₹10 per share); UNM Foundation has no revenue or turnover as a Section 8 entity.
Transaction is classified as a related party transaction conducted at arm's length, disclosed under SEBI Listing Regulations Regulation 30.